AGIBOT GO-3 Preview is an embodied AI model that forecasts what its cameras will see next, then picks matching actions.

Tired of the limitations of traditional Retrieval-Augmented Generation (RAG) systems? Dive into our groundbreaking guide to ...

Recursion Pharmaceuticals reported Q3 2026 revenue of US$18.55 million and a net loss of US$119.04 million, while ...

Recursion Pharmaceuticals (NasdaqGS:RXRX) reported positive Phase 2 data for oral MEK1/2 inhibitor REC-4881 in familial ...

Recursion Pharmaceuticals (NASDAQ:RXRX) has counted Nvidia as an investor since 2023 when Jensen Huang's company invested ...

Anthropic has warned that it may be approaching a stage in artificial intelligence development where AI systems significantly ...

Improvement" Take on a Life of Its Own?"If we keep having an AI improve itself, wouldn't explosive evolution (Recursive ...

Recursion said it expects to launch its first registrational trial in the second half of this year for its lead candidate REC-4881 based on talks with the FDA, after the oral familial adenomatous ...

Anthropic's amended S-1 says future models may soon hit its threshold for AI-driven recursive self-improvement. No current ...

Recursion’s Q3 2026 earnings call highlighted REC-4881 FAP data, REC-1245 tumor responses, $749 million in pro forma cash and ...

In an amended S-1/A filing submitted to the SEC on November 2, 2026, Anthropic warned of the possibility that it is ...

SemiAnalysis’s GDPx benchmark tested 13 frontier AI models on 206 real professional tasks. Best score: 12%. Finance and legal returned zero across every model.